Skip to Content

3,912 Results Found

  • Article
  • Open Access
21 Citations
8,993 Views
14 Pages

NaB, the metabolite of cinnamon and sodium salt of benzoic acid is a commonly used food and beverage preservative. Various studies have investigated NaB for its effects on different cellular models. However, the effects of NaB on cancer cell viabilit...

(This article belongs to the Section Chemical Biology)
  • Article
  • Open Access
8 Citations
3,886 Views
12 Pages

Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study)

  • Elisa Giommoni,
  • Evaristo Maiello,
  • Vanja Vaccaro,
  • Ermanno Rondini and ,
  • Caterina Vivaldi,
  • Giampaolo Tortora,
  • Laura Toppo,
  • Guido Giordano,
  • Tiziana Pia Latiano and
  • Francesco Di Costanzo
  • + 9 authors+ 4 authors

8 May 2021

Background: Relevant improvement in first-line treatment of metastatic pancreatic cancer (mPC) was provided by FOLFIRINOX and by gemcitabine (gem) plus nab-paclitaxel (Nab-p) regimens. Regardless of the first-line treatment survival benefit, most pat...

(This article belongs to the Section Gastrointestinal Oncology)
  • Article
  • Open Access
14 Citations
4,118 Views
17 Pages

The Effect of Sodium Butyrate on Adventitious Shoot Formation Varies among the Plant Species and the Explant Types

  • Myoung Hui Lee,
  • Jiyoung Lee,
  • Seung Hee Choi,
  • Eun Yee Jie and ,
  • Jae Cheol Jeong,
  • Cha Young Kim and
  • Suk Weon Kim
  • + 2 authors+ 0 author

10 November 2020

Histone acetylation plays an important role in plant growth and development. Here, we investigated the effect of sodium butyrate (NaB), a histone deacetylase inhibitor, on adventitious shoot formation from protoplast-derived calli and cotyledon expla...

(This article belongs to the Section Molecular Plant Sciences)
  • Article
  • Open Access
15 Citations
3,778 Views
19 Pages

Sodium Butyrate Alleviates Heat Stress-Induced Oxidative Stress and Skeletal Muscle Homeostasis Disruption by Promoting Autophagy in Mice

  • Jiayin Lu,
  • Chaoyue Li,
  • Tong Zhao,
  • Fengyang Li and ,
  • Zhichao Yao,
  • Yajie Dong,
  • Zeen Gong,
  • Yi Yan,
  • Xiaomao Luo and
  • Haidong Wang
  • + 5 authors+ 0 author

15 February 2025

Background: The gradual rise in global temperatures can affect skeletal muscle development and intestinal microorganisms. However, the influence of microbial metabolites on skeletal muscle homeostasis under heat stress (HS) remains unclear. Methods:...

(This article belongs to the Section Nutrition and Metabolism)
  • Article
  • Open Access
4 Citations
1,576 Views
18 Pages

8 August 2025

Background/Objectives: Colorectal cancer (CRC) remains a leading cause of cancer-related mortality globally, highlighting the urgent need for novel therapeutic strategies. This study aimed to investigate the anticancer potential of sodium pentaborate...

(This article belongs to the Special Issue Boron-Containing Compounds: Identification, Synthesis, Biological Actions and Pharmacology)
  • Article
  • Open Access
715 Views
13 Pages

Background/Objectives: Hematopoietic stem cells (HSCs) sustain lifelong blood cell production and hold therapeutic promise, yet their ex vivo expansion remains constrained by an incomplete understanding of the metabolic and cellular mechanisms govern...

(This article belongs to the Section Cell Metabolism)
  • Review
  • Open Access
32 Citations
11,170 Views
23 Pages

Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety

  • Md Sazzad Hassan,
  • Niranjan Awasthi,
  • Saisantosh Ponna and
  • Urs von Holzen

Taxanes (paclitaxel and docetaxel) are one of the most useful classes of anticancer drugs. Taxanes are highly hydrophobic; therefore, these drugs must be dissolved in organic solvents (polysorbate or Cremophor EL), which contribute to their toxicitie...

(This article belongs to the Section Nanomedicine and Nanobiology)
  • Article
  • Open Access
12 Citations
3,750 Views
13 Pages

Sodium Butyrate (NaB) and Sodium Propionate (NaP) Reduce Cyclin A2 Expression, Inducing Cell Cycle Arrest and Proliferation Inhibition of Different Breast Cancer Subtypes, Leading to Apoptosis

  • José-Noel Ibrahim,
  • Sandy El-Hakim,
  • Josiane Semaan,
  • Stéphanie Ghosn and ,
  • Hiba El Ayoubi,
  • Arpiné Ardzivian Elnar,
  • Najat Tohme and
  • Charbel El Boustany
  • + 3 authors+ 0 author

Sodium butyrate (NaB) and sodium propionate (NaP) have recently garnered attention for their role in regulating inflammation and controlling signaling pathways of cell growth and apoptosis, potentially preventing cancer development. However, their th...

(This article belongs to the Section Immunology and Immunotherapy)
  • Article
  • Open Access
34 Citations
11,508 Views
20 Pages

Effect of Production Technique on Pilsner-Style Non-Alcoholic Beer (NAB) Chemistry and Flavor

  • Nils Rettberg,
  • Scott Lafontaine,
  • Christian Schubert,
  • Johanna Dennenlöhr and ,
  • Laura Knoke,
  • Patrícia Diniz Fischer,
  • Johannes Fuchs and
  • Sarah Thörner
  • + 3 authors+ 0 author

The sensory, volatile, and physiochemical profiles of nineteen commercial non-alcoholic pilsner-style beers produced by different production techniques were analyzed and compared with a dry-hopped non-alcoholic IPA. NABs made only with either physica...

(This article belongs to the Section Tea, Coffee, Water, and Other Non-Alcoholic Beverages)
  • Article
  • Open Access
20 Citations
5,699 Views
14 Pages

Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines

  • Lukas M. Braun,
  • Simon Lagies,
  • Jessica Guenzle,
  • Stefan Fichtner-Feigl and ,
  • Uwe A. Wittel and
  • Bernd Kammerer
  • + 1 author+ 0 author

19 May 2020

Pancreatic ductal adenocarcinoma (PDAC) correlates with high mortality and is about to become one of the major reasons for cancer-related mortality in the next decades. One reason for that high mortality is the limited availability of effective chemo...

  • Article
  • Open Access
9 Citations
4,515 Views
15 Pages

Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC)

  • Qi Song,
  • Herui Wang,
  • Dongxian Jiang,
  • Chen Xu and ,
  • Jing Cui,
  • Qi Zhang,
  • Haixing Wang,
  • Jie Huang,
  • Jieakesu Su and
  • Yingyong Hou
  • + 7 authors+ 2 authors

23 September 2021

Paclitaxel-based chemotherapy is a treatment option for advanced esophageal squamous cell carcinoma (ESCC). However, the development of chemoresistance leads to treatment failure, and the underlying mechanism remains elusive. We investigated the mech...

(This article belongs to the Collection Drug Resistance and Novel Therapies in Cancers)
  • Article
  • Open Access
13 Citations
1,458 Views
6 Pages

Clinical Outcomes of Women with Metastatic Breast Cancer Treated with Nab-Paclitaxel: Experience from a Single Academic Cancer Centre

  • S. Dent,
  • J. Fraser,
  • N. Graham,
  • M. Campbell and ,
  • S. Hopkins and
  • G. Dranitsaris
  • + 1 author+ 0 author

1 February 2013

Background: Nab-paclitaxel is a solvent-free, taxane-based chemotherapy approved for the treatment of metastatic breast cancer (mbc). This study reports clinical benefit and toxicities experienced by women with mbc treated with nab-paclitaxel at the...

  • Article
  • Open Access
1 Citations
1,338 Views
17 Pages

Targeting the c-Met/VEGFR Pathway to Boost Nab-Paclitaxel Efficacy in Gastric Cancer: Preclinical Insights

  • Jennifer Huang,
  • Quinn Kaurich,
  • Md Sazzad Hassan,
  • Urs von Holzen and
  • Niranjan Awasthi

3 February 2026

Combination chemotherapy regimens are commonly employed to treat advanced gastric adenocarcinoma (GAC), yet median survival remains less than one year. Nab-paclitaxel has demonstrated significant antitumor activity in preclinical GAC models. Overexpr...

(This article belongs to the Special Issue Gastrointestinal Cancer: From Cellular and Molecular Mechanisms to Therapeutic Opportunities)
  • Article
  • Open Access
2 Citations
2,020 Views
11 Pages

Efficacy and Safety Analysis of Nab-Paclitaxel Treatment in Elderly Patients with HER-2 Negative Metastatic Breast Cancer: NEREIDE Study

  • Giuseppina Rosaria Rita Ricciardi,
  • Alessandro Russo,
  • Maria Vita Sanò,
  • Angela Prestifilippo and ,
  • Antonio Russo,
  • Vittorio Gebbia,
  • Livio Blasi,
  • Dario Giuffrida,
  • Giuseppa Scandurra and
  • Vincenzo Adamo
  • + 10 authors+ 5 authors

20 June 2025

Background: Older women represent a significant and increasing population of patients with breast cancer, accounting for over 40% of new cases of breast cancer. However, this growing subgroup of patients is still underrepresented in clinical trials,...

(This article belongs to the Special Issue Molecular Pathology and Human Cancers)
  • Article
  • Open Access
4 Citations
3,477 Views
11 Pages

Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational Study

  • Alberto Servetto,
  • Antonio Santaniello,
  • Fabiana Napolitano,
  • Francesca Foschini and ,
  • Roberta Marciano,
  • Eleonora Mozzillo,
  • Priscilla Cascetta,
  • Anna Rita Amato,
  • Maria Rosaria Augurio and
  • Roberto Bianco
  • + 9 authors+ 4 authors

30 September 2021

Patients with locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC) do not present distant metastases but are not eligible for surgery upfront. Chemotherapy regimens, such as FOLFIRINOX (FFN) or nab-paclitaxel plus gemcitabine (GemNab) in com...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
8 Citations
4,013 Views
15 Pages

Background/Objectives: The study objective was to determine the physicochemical stability of nab-paclitaxel (Pazenir) ready-to-use (RTU) dispersion for infusion in original glass vials and ready-to-administer (RTA) infusion dispersion in EVA infusion...

(This article belongs to the Section Pharmaceutical Technology, Manufacturing and Devices)
  • Article
  • Open Access
3 Citations
2,171 Views
14 Pages

The Effect of Kappa Phases on Tribocorrosion Behaviour of Nickel Aluminum Bronze (NAB) and Manganese Aluminum Bronze (MAB)

  • Carlos Berlanga-Labari,
  • Adrián Claver,
  • María Victoria Biezma-Moraleda and
  • José Fernández-Palacio

Nickel aluminum bronze (NAB) and manganese aluminum bronze (MAB) are widely used in propulsion and seawater handling systems in naval platforms due to their attractive combination of mechanical strength, toughness, and very low susceptibility to mari...

  • Systematic Review
  • Open Access
39 Citations
8,606 Views
11 Pages

Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine

  • Francesco Di Costanzo,
  • Federica Di Costanzo,
  • Lorenzo Antonuzzo,
  • Ernesto Mazza and
  • Elisa Giommoni

8 January 2023

Pancreatic cancer (PC) is one of the most lethal tumors in Europe with an overall 5-year survival rate of 5%. Since 1992, gemcitabine (Gem) has been the treatment of choice for metastatic disease with significant improvement in median overall surviva...

(This article belongs to the Special Issue Advanced Pancreatic Cancer)
  • Article
  • Open Access
2 Citations
2,170 Views
17 Pages

8 October 2024

Laser Hot Wire (LHW) Directed Energy Deposition (DED) Additive Manufacturing (AM) processes are capable of manufacturing parts with a high deposition rate. There is a growing research interest in replacing large cast Nickel Aluminum Bronze (NAB) comp...

(This article belongs to the Special Issue Recent Developments in Laser Additive Manufacturing of Metallic Materials)
  • Review
  • Open Access
107 Citations
9,316 Views
11 Pages

Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis

  • Sara Pusceddu,
  • Michele Ghidini,
  • Martina Torchio,
  • Francesca Corti and ,
  • Gianluca Tomasello,
  • Monica Niger,
  • Natalie Prinzi,
  • Federico Nichetti,
  • Andrea Coinu and
  • Fausto Petrelli
  • + 9 authors+ 4 authors

5 April 2019

Gemcitabine and nab-paclitaxel (GEM-NAB) and the combination of 5-fluorouracil, oxaliplatin, and irinotecan (FOLFIRINOX) are valid first-line options for advanced or metastatic pancreatic cancer (mPC). However, no randomized trials comparing the two...

(This article belongs to the Special Issue Advances in Pancreatic Cancer Research)
  • Article
  • Open Access
3 Citations
1,841 Views
13 Pages

Colorectal cancer (CRC) is associated with factors such as an unhealthy diet, physical inactivity, obesity, diabetes, and chronic inflammatory conditions like inflammatory bowel disease (IBD), as well as TP53 mutations, which are observed in a broad...

(This article belongs to the Section Molecular Medicine)
  • Article
  • Open Access
37 Citations
7,710 Views
9 Pages

16 September 2015

NiAl bronze (NAB) alloy is prepared by using friction stir processing (FSP) technique at a tool rotation rate of 1200 rpm and a traverse speed of 150 mm/min. A post heat treatment is performed at the temperature of 675 °C. The effect of heat treatmen...

(This article belongs to the Special Issue Casting Alloy Design and Modification)
  • Review
  • Open Access
41 Citations
6,645 Views
17 Pages

Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer

  • Annalisa Comandatore,
  • Benoit Immordino,
  • Rita Balsano,
  • Mjriam Capula and ,
  • Ingrid Garajovà,
  • Joseph Ciccolini,
  • Elisa Giovannetti and
  • Luca Morelli
  • + 3 authors+ 0 author

In recent years, a growing number of studies have evaluated the role of exosomes in pancreatic ductal adenocarcinoma cancer (PDAC) demonstrating their involvement in a multitude of pathways, including the induction of chemoresistance. The aim of this...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Case Report
  • Open Access
22 Citations
1,687 Views
4 Pages

1 October 2013

Drug-induced lupus erythematosus (DILE) syndromes are documented complications of chemotherapeutic agents, including paclitaxel. Subacute cutaneous lupus erythematosus (SCLE) is a distinct DILE syndrome presenting with characteristic annular or papul...

  • Article
  • Open Access
10 Citations
3,375 Views
11 Pages

Real World First-Line Treatments and Outcomes of Nab-Paclitaxel Plus Gemcitabine, mFOLFIRINOX and GEMOX in Unresectable Pancreatic Cancer from a Chinese Single Institution

  • Qi Quan,
  • Yixing Wang,
  • Fenghua Wang,
  • Dongsheng Zhang and ,
  • Xiuxing Chen,
  • Wenzhuo He,
  • Bei Zhang and
  • Guifang Guo
  • + 3 authors+ 0 author

30 December 2020

Background: There have not been any head-to-head prospective studies to compare the effects of different chemotherapy regimens as first-line treatments for unresectable pancreatic cancer (UPC). We aimed to compare the effectiveness of nab-paclitaxel...

  • Case Report
  • Open Access
1 Citations
3,158 Views
10 Pages

Ampullary adenocarcinoma is a rare malignancy that lacks standard systemic treatment. We describe a case of recurrent metastatic ampullary adenocarcinoma of the pancreaticobiliary subtype treated with nanoparticle albumin-bound (nab)-paclitaxel and g...

(This article belongs to the Section Molecular and Translational Medicine)
  • Study Protocol
  • Open Access
6 Citations
5,241 Views
22 Pages

Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol

  • Jun Gong,
  • Arsen Osipov,
  • Jeremy Lorber,
  • Mourad Tighiouart and ,
  • Albert K. Kwan,
  • Hayato Muranaka,
  • Rasaq Akinsola,
  • Sandrine Billet,
  • Abrahm Levi and
  • Andrew E. Hendifar
  • + 8 authors+ 3 authors

Advanced pancreatic cancer is underscored by progressive therapeutic resistance and a dismal 5-year survival rate of 3%. Preclinical data demonstrated glutamine supplementation, not deprivation, elicited antitumor effects against pancreatic ductal ad...

(This article belongs to the Section Molecular and Translational Medicine)
  • Article
  • Open Access
11 Citations
3,764 Views
12 Pages

Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients

  • Valeria Merz,
  • Alessandro Cavaliere,
  • Carlo Messina,
  • Massimiliano Salati and ,
  • Camilla Zecchetto,
  • Simona Casalino,
  • Michele Milella,
  • Orazio Caffo and
  • Davide Melisi
  • + 4 authors+ 0 author

30 April 2020

Pancreatic cancer is one of the most lethal solid tumors. In many European countries gemcitabine plus nab-paclitaxel is the preferred first-line treatment. An increasing number of patients are eligible for second-line therapy, but the best regimen is...

  • Systematic Review
  • Open Access
424 Views
27 Pages

Pathological Complete Response to Nab-Paclitaxel–Containing Neoadjuvant Regimens in Early Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

  • Rasha Aziz Attia Salama,
  • Mohamed El-Tanani,
  • Syed Arman Rabbani,
  • Mohamedanas Patni and ,
  • Bhoomendra Bhongade,
  • Rasha Babiker,
  • Shakta Mani Satyam,
  • Imran Rashid Rangraze,
  • Adil Farooq Wali and
  • Omer Eladil Abdalla
  • + 6 authors+ 1 author

21 September 2026

Background: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited targeted treatment options. This systematic review and meta-analysis evaluated pathological complete response (pCR) outcomes associated with nab-pacl...

(This article belongs to the Special Issue Advances in Clinical Approaches to Breast Cancer Diagnosis and Treatment)
  • Article
  • Open Access
8 Citations
3,612 Views
12 Pages

Treatment Outcomes and Prognostic Factors of Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy after Modified FOLFIRINOX in Unresectable Pancreatic Cancer

  • Takafumi Mie,
  • Takashi Sasaki,
  • Tsuyoshi Takeda,
  • Takeshi Okamoto and ,
  • Tsuyoshi Hamada,
  • Takahiro Ishitsuka,
  • Manabu Yamada,
  • Hiroki Nakagawa,
  • Takaaki Furukawa and
  • Naoki Sasahira
  • + 8 authors+ 3 authors

5 January 2023

Outcomes and prognostic factors of second-line gemcitabine plus nab-paclitaxel (GnP) after modified FOLFIRINOX (mFFX) for unresectable pancreatic cancer were unclear. We retrospectively analyzed consecutive patients with unresectable pancreatic cance...

(This article belongs to the Special Issue Advanced Pancreatic Cancer)
  • Article
  • Open Access
6 Citations
4,530 Views
17 Pages

Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study)

  • Sandor Schokker,
  • Stephanie O. van der Woude,
  • Jessy Joy van Kleef,
  • Daan J. van Zoen and ,
  • Martijn G. H. van Oijen,
  • Banafsche Mearadji,
  • Ludo F. M. Beenen,
  • Charlotte I. Stroes,
  • Cynthia Waasdorp and
  • Hanneke W. M. van Laarhoven
  • + 11 authors+ 6 authors

14 June 2019

First-line triplet chemotherapy including a taxane may prolong survival in patients with metastatic esophagogastric cancer. The added toxicity of the taxane might be minimized by using nab-paclitaxel. The aim of this phase I study was to determine th...

  • Article
  • Open Access
24 Citations
5,850 Views
12 Pages

Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study

  • Nicolas Williet,
  • Angelica Petrillo,
  • Gaël Roth,
  • Michele Ghidini and ,
  • Mila Petrova,
  • Julien Forestier,
  • Anthony Lopez,
  • Audrey Thoor,
  • Lucie Weislinger and
  • Jean Marc Phelip
  • + 7 authors+ 2 authors

4 June 2021

Background: Gemcitabine/nab-paclitaxel (GN) and FOLFIRINOX (FFX) are two standard first-line therapies for metastatic pancreatic cancer (PC) but have rarely been compared, especially in patients with locally advanced PC (LAPC). Methods: This is a ret...

(This article belongs to the Special Issue Combination and Innovative Therapies for Pancreatic Cancer)
  • Article
  • Open Access
3 Citations
3,400 Views
9 Pages

Excretion of the Polymyxin Derivative NAB739 in Murine Urine

  • Martti Vaara,
  • Timo Vaara,
  • Janis Kuka,
  • Eduards Sevostjanovs and ,
  • Solveiga Grinberga,
  • Maija Dambrova and
  • Edgars Liepinsh
  • + 2 authors+ 0 author

Extremely multiresistant strains of Enterobacteriaceae are emerging and spreading at a worrisome pace. Polymyxins are used as the last-resort therapy against such strains, in spite of their nephrotoxicity. We have previously shown that novel polymyxi...

(This article belongs to the Section Mechanisms and Structural Biology of Antibiotic Action)
  • Article
  • Open Access
9 Citations
3,291 Views
15 Pages

Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy

  • Yi Tat Tong,
  • Zongshan Lai,
  • Matthew H. G. Katz,
  • Laura R Prakash and ,
  • Hua Wang,
  • Deyali Chatterjee,
  • Michael Kim,
  • Ching-Wei D. Tzeng,
  • Jeffrey E. Lee and
  • Huamin Wang
  • + 11 authors+ 6 authors

4 May 2023

Neoadjuvant FOLFIRINOX and gemcitabine/nab-paclitaxel (GemNP) therapies are increasingly used to treat patients with pancreatic ductal adenocarcinoma (PDAC). However, limited data are available on their clinicopathologic prognosticators. We examined...

(This article belongs to the Special Issue Neoadjuvant Therapies in Pancreatic Cancer)
  • Article
  • Open Access
43 Citations
6,921 Views
10 Pages

Second-Line Gemcitabine Plus Nab-Paclitaxel for Patients with Unresectable Advanced Pancreatic Cancer after First-Line FOLFIRINOX Failure

  • Naoki Mita,
  • Takuji Iwashita,
  • Shinya Uemura,
  • Kensaku Yoshida and ,
  • Yuhei Iwasa,
  • Nobuhiro Ando,
  • Keisuke Iwata,
  • Mitsuru Okuno,
  • Tsuyoshi Mukai and
  • Masahito Shimizu
  • + 5 authors+ 0 author

FOLFIRINOX (FX) and gemcitabine (GEM) plus nab-paclitaxel (GnP) have been reported as effective regimens for unresectable advanced pancreatic cancer (APC). FX may be more effective but is also associated with more adverse events (AEs). Therefore, fir...

(This article belongs to the Special Issue Current Standards and New Innovative Approaches for Treatment of Pancreatic Cancer)
  • Article
  • Open Access
1 Citations
5,034 Views
7 Pages

Effect of Mirogabalin on Chemotherapy-Induced Peripheral Neuropathy Caused by Gemcitabine plus Nab-Paclitaxel Therapy in Pancreatic Cancer Patients: A Pilot Study

  • Yusuke Takasaki,
  • Toshio Fujisawa,
  • Mako Ushio,
  • Sho Takahashi and ,
  • Wataru Yamagata,
  • Akinori Suzuki,
  • Koichi Ito,
  • Kazushige Ochiai,
  • Ko Tomishima and
  • Hiroyuki Isayama
  • + 6 authors+ 1 author

6 August 2022

Background: Gemcitabine/nab-paclitaxel therapy (GnP) is widely used to treat pancreatic cancer (PC), but chemotherapy-induced peripheral neuropathy (CIPN) is common. The CIPN is also reported to be related by microvascular damage as the basis for tox...

(This article belongs to the Section Neurovascular Diseases)
  • Article
  • Open Access
1 Citations
1,087 Views
21 Pages

Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center Retrospective Observational Study

  • Kazuki Watabe,
  • Motoyasu Kan,
  • Izumi Ohno,
  • Sodai Uchida and ,
  • Taiga Sudo,
  • Koki Yokozuka,
  • Akinori Abe,
  • Yoshiki Nakaya,
  • Yoshiki Ogane and
  • Jun Kato
  • + 15 authors+ 10 authors

7 January 2026

Background: Pancreatic cancer (PC) is a refractory malignancy with a dismal prognosis. For unresectable PC, gemcitabine plus nab-paclitaxel (GnP) is widely used as first-line chemotherapy. During treatment, patients may require unplanned hospitalizat...

(This article belongs to the Section Clinical Research in Cancer)
  • Article
  • Open Access
8 Citations
3,438 Views
13 Pages

Study of Effect of Nickel Content on Tribocorrosion Behaviour of Nickel–Aluminium–Bronzes (NABs)

  • C. Berlanga-Labari,
  • A. Claver,
  • M. V. Biezma-Moraleda and
  • José F. Palacio

The simultaneous existence of mechanical erosion and electrochemical corrosion is a common scenario for engineering alloys used in marine environments, such as pump impellers and valves. Nickel–aluminium–bronzes (NABs) are widely used all...

(This article belongs to the Special Issue Corrosion and Tribocorrosion Behavior of Metals and Alloys)
  • Article
  • Open Access
46 Citations
6,842 Views
19 Pages

Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review

  • Fabiana Napolitano,
  • Luigi Formisano,
  • Alessandro Giardino,
  • Roberto Girelli and ,
  • Alberto Servetto,
  • Antonio Santaniello,
  • Francesca Foschini,
  • Roberta Marciano,
  • Eleonora Mozzillo and
  • Roberto Bianco
  • + 9 authors+ 4 authors

13 July 2019

The optimal therapeutic strategy for locally advanced pancreatic cancer patients (LAPC) has not yet been established. Our aim is to evaluate how surgery after neoadjuvant treatment with either FOLFIRINOX (FFN) or Gemcitabine-NabPaclitaxel (GemNab) af...

(This article belongs to the Special Issue Advances in Pancreatic Cancer Research)
  • Article
  • Open Access
2 Citations
4,759 Views
12 Pages

12 February 2024

Immunotherapy has shown clinical benefit in patients with non-small-cell lung cancer (NSCLC). Due to the limited response of monotherapy, combining immune checkpoint inhibitors (ICIs) and chemotherapy is considered a treatment option for advanced NSC...

(This article belongs to the Topic Pharmacokinetic and Pharmacodynamic Modelling in Drug Discovery and Development)
  • Article
  • Open Access
14 Citations
4,467 Views
14 Pages

NAB 2-Expressing Cancer-Associated Fibroblast Promotes HNSCC Progression

  • So-Young Choi,
  • Su Young Oh,
  • Soo Hyun Kang,
  • Sung-Min Kang and ,
  • Jinkyung Kim,
  • Heon-Jin Lee,
  • Tae-Geon Kwon,
  • Jin-Wook Kim and
  • Su-Hyung Hong
  • + 4 authors+ 0 author

19 March 2019

Cancer-associated fibroblast (CAF)-specific proteins serve as both prognostic biomarkers and targets for anticancer drugs. In this study, we investigated the role of NGFI-A-binding protein (NAB)2 derived from CAFs in the progression of head and neck...

  • Article
  • Open Access
3 Citations
2,238 Views
17 Pages

13 December 2023

Salt stress is a significant environmental factor affecting plant growth and development, with NaCl stress being one of the most common types of salt stress. The halophyte, Tamarix ramosissima Ledeb (T. ramosissima), is frequently utilized for the af...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
35 Citations
6,291 Views
9 Pages

22 August 2017

NaOH-modified TiOF2 was successfully prepared using a modified low-temperature hydrothermal method. Scanning electron microscopy shows that NaOH-modified TiOF2 displayed a complex network shape with network units of about 100 nm. The structures of Na...

(This article belongs to the Special Issue Nanomaterials for Environmental Purification and Energy Conversion)
  • Feature Paper
  • Article
  • Open Access
14 Citations
4,583 Views
18 Pages

A Thermo-Mechanical Analysis of Laser Hot Wire Additive Manufacturing of NAB

  • Glenn W. Hatala,
  • Qian Wang,
  • Edward W. Reutzel,
  • Charles R. Fisher and
  • Jennifer K. Semple

25 June 2021

There is increased interest in using nickel aluminum bronze (NAB) alloys in large-scale directed energy deposition additive manufacturing (DEDAM) processes for maritime applications, but one challenge lies in the component distortion that results fro...

(This article belongs to the Section Computation and Simulation on Metals)
  • Article
  • Open Access
6 Citations
3,065 Views
7 Pages

22 September 2022

Alkali metal (M = Na, K) salts of the [CB11H12]− anion have attracted increasing attention in many fields such as catalysis and all-solid-state batteries. However, tedious and low-yielding synthetic methods have seriously limited their applicat...

(This article belongs to the Special Issue Advances of Carborane Compounds)
  • Review
  • Open Access
57 Citations
8,747 Views
28 Pages

Recent Advances in Applications of Co-B Catalysts in NaBH4-Based Portable Hydrogen Generators

  • Valentina I. Simagina,
  • Anna M. Ozerova,
  • Oksana V. Komova and
  • Olga V. Netskina

17 February 2021

This review highlights the opportunities of catalytic hydrolysis of NaBH4 with the use of inexpensive and active Co-B catalysts among the other systems of hydrogen storage and generation based on water reactive materials. This process is important fo...

(This article belongs to the Special Issue Cobalt Catalysis: Recent Progress and Developments)
  • Article
  • Open Access
1 Citations
3,316 Views
14 Pages

T330M Substitution in the Sodium-Dependent Phosphate Transporter NaPi2b Abolishes the Efficacy of Monoclonal Antibodies Against MX35 Epitope

  • Leisan F. Bulatova,
  • Vera S. Skripova,
  • Aisylu R. Sagdeeva,
  • Ramilia A. Vlasenkova and ,
  • Tatiana A. Bugaenko,
  • Rezeda R. Galimova,
  • Alfiya I. Nesterova,
  • Yuliya V. Filina and
  • Ramziya G. Kiyamova
  • + 4 authors+ 0 author

Background: Monoclonal antibodies against the sodium-dependent phosphate transporter NaPi2b (SLC34A2) represent a promising approach in the treatment of ovarian and lung cancer. Of particular interest is the potential cancer-specific MX35 epitope of...

  • Article
  • Open Access
30 Citations
5,410 Views
10 Pages

Low Temperature Synthesis of Phase Pure MoAlB Powder in Molten NaCl

  • Cheng Liu,
  • Zhaoping Hou,
  • Quanli Jia,
  • Xueyin Liu and
  • Shaowei Zhang

9 February 2020

MoAlB fine powders were prepared in molten NaCl from Al, B and Mo powders. The effects of key parameters affecting the synthesis process and phase morphology were examined and the underpinning mechanisms proposed. MoAlB product particles exhibited di...

(This article belongs to the Special Issue High Temperature Ceramic Materials)
  • Article
  • Open Access
1,103 Views
17 Pages

lncRNA NAS1 Deficiency Drives Cisplatin Resistance via NR2F1-Mediated TGFB1/NF-κB Signaling Axis in NSCLC

  • Xianrong Lin,
  • Yuxin Wu,
  • Qi Wu,
  • Wenjun Tao and ,
  • Jun Zhang and
  • Jun Zhou
  • + 1 author+ 0 author

3 April 2026

Background: Cisplatin resistance remains a major challenge in the treatment of non-small cell lung cancer (NSCLC). Although long non-coding RNAs (lncRNAs) have been implicated in chemotherapy resistance, their specific roles and underlying mechanisms...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
8 Citations
2,229 Views
11 Pages

Electrophoretically Deposited TiB2 Coatings in NaF-AlF3 Melt for Corrosion Resistance in Liquid Zinc

  • Tao Jiang,
  • Junjie Xu,
  • Chuntao Ge,
  • Jie Pang and ,
  • Jun Zhang,
  • Geir Martin Haarberg and
  • Saijun Xiao
  • + 2 authors+ 0 author

12 August 2024

Molten salt electrophoretic deposition is a novel method for preparing coatings of transition metal borides such as TiB2, which has emerged in recent years. To broaden the applications of transition metal boride coatings prepared by this method, this...

(This article belongs to the Special Issue Advanced Anticorrosion Coatings and Coating Testing)

of 79